Literature DB >> 6274159

Cyclic AMP-dependent and -independent effects of prostaglandins on the contraction-relaxation cycle of spontaneously beating isolated rat atria.

T Metsä-Ketelä.   

Abstract

The effects of prostaglandin (PG) F2 alpha, E2, E1 and I2 on the amplitude, duration of the contraction-relaxation cycle (CRC), the second derivative of developed tension and the cyclic adenosine-3', 5' monophosphate (cAMP) level and on 45Ca uptake were studied in isolated spontaneously beating rat atria. The order of capacity to generate positive inotropic effects was PGF2 alpha greater than PGE2 greater than PGE1 approximately PGI2. Only PGI2 and PGE1 decreased the duration of CRC. PGF2 alpha produced an increase during the first 2.5 min, whereafter the duration returned to the initial level, PGE2 had no significant effect on the shape of the CRC. The ratios of the maximum and minimum of the second derivative of the developed tension were reduced by PGI2 and PGF2 alpha 2.5 and 5 min after administration, respectively. The 45Ca uptake was stimulated equally by all of the tested PGs, but only PGI2 and PGE1 could significantly increase the cAMP level. The results do not support the conception that cAMP could mediate the positive inotropic effect of PGs. Rather the contrary, cAMP, increased by PGE1 or PGI2, could be responsible for increased relaxation, which might prevent the full development of tension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274159     DOI: 10.1111/j.1748-1716.1981.tb06847.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  9 in total

1.  How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension.

Authors:  Rebecca R Vanderpool; Ankit A Desai; Shannon M Knapp; Marc A Simon; Aiden Abidov; Jason X-J Yuan; Joe G N Garcia; Lillian M Hansen; Steven R Knoper; Robert Naeije; Franz P Rischard
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

2.  Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: a tissue Doppler imaging study.

Authors:  Adriana Pavelescu; Robert Naeije
Journal:  Eur J Appl Physiol       Date:  2011-07-23       Impact factor: 3.078

3.  The influence of prostacyclin (PGI2) on contractile properties of isolated right ventricle of rat heart.

Authors:  M Pavlović; D Petković; M Cvetković; D J Macut; K Zdjelar; M Nesić; O Bosnić; R Radulović; M Mihajlović
Journal:  Experientia       Date:  1995-09-29

4.  Role of prostaglandin-mediated cyclic AMP formation in protein kinase C-dependent secretion of atrial natriuretic peptide in rat cardiomyocytes.

Authors:  D J Church; V Van der Bent; M B Vallotton; U Lang
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

5.  Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes.

Authors:  M Fontana; H Olschewski; A Olschewski; K-D Schlüter
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

6.  Inotropic actions of eicosanoids.

Authors:  K Schrör; T Hohlfeld
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

7.  The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo.

Authors:  Hille Kisch-Wedel; Gregor Kemming; Franz Meisner; Michael Flondor; Wolfgang M Kuebler; Sebastian Bruhn; Carolina Koehler; Bernhard Zwissler
Journal:  Intensive Care Med       Date:  2003-08-08       Impact factor: 17.440

8.  Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study.

Authors:  Jing-Hui Li; Hong-Da Zhang; Zhen-Zhen Wang; Qing-Qing Lu; Dong Li; Tian-Yu Lian; Zi-Chao Lv; Xin Jiang; Yan Wu; Jue Ye; Shihua Zhao; Zhenwen Yang
Journal:  Front Pharmacol       Date:  2019-01-21       Impact factor: 5.810

9.  Response of non-failing hypertrophic rat hearts to prostaglandin F2α.

Authors:  Anna Maria Krstic; Sarbjot Kaur; Marie-Louise Ward
Journal:  Curr Res Physiol       Date:  2019-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.